Immunovant (IMVT) Amortizatization of Intangibles (2020 - 2026)

Immunovant filings provide 6 years of Amortizatization of Intangibles readings, the most recent being $25000.0 for Q4 2025.

  • Quarterly Amortizatization of Intangibles rose 8.7% to $25000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $95000.0 through Dec 2025, down 73.83% year-over-year, with the annual reading at $133000.0 for FY2025, 88.23% down from the prior year.
  • Amortizatization of Intangibles hit $25000.0 in Q4 2025 for Immunovant, up from $24000.0 in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $295000.0 in Q4 2023 and bottomed at $22000.0 in Q3 2024.
  • Average Amortizatization of Intangibles over 5 years is $189600.0, with a median of $274500.0 recorded in 2021.
  • The largest annual shift saw Amortizatization of Intangibles soared 80.26% in 2021 before it tumbled 92.49% in 2024.
  • Immunovant's Amortizatization of Intangibles stood at $280000.0 in 2021, then grew by 1.43% to $284000.0 in 2022, then increased by 3.87% to $295000.0 in 2023, then plummeted by 92.2% to $23000.0 in 2024, then increased by 8.7% to $25000.0 in 2025.
  • Per Business Quant, the three most recent readings for IMVT's Amortizatization of Intangibles are $25000.0 (Q4 2025), $24000.0 (Q3 2025), and $24000.0 (Q2 2025).